BioElectronics Announces ActiPatch(R) Available on
Post# of 617763
FREDERICK, MD--(Marketwired - Feb 9, 2017) - BioElectronics Corporation (
ActiPatch is for the 100+ million US chronic pain sufferers. The easy to wear drug-free medical device provides 720-hours (90, 8-hour treatments) of on/off therapy for $29.95. ActiPatch provides:
- Impressive Efficacy
- No harmful side effects
- A 50% Reduction in Medication Use, including opioids
- Exceptional Consumer Acceptance
- Demonstrated Marketability
- Safe adjunctive or alternative therapy to pain killers, including narcotics.
The Amazon website and the Company's website www.tryActiPatch.com have available the Company's Award Winning Try & Tell 7-Day Trial Marketing product for $9.95. The 24/7 Trial Device introduces consumers to significant long-lasting pain relief that allows a full night's sleep and restoration of daily activities without any harmful side effects.
"I expect the resounding success that we've had in the United Kingdom to be mirrored in the United States," says Chris Russell, VP of Marketing at BioElectronics. "We are consistently a top selling analgesic device for retailers like Amazon in the UK. Now with US FDA market clearance, we anticipate similar success in the US."
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; and Allay® Menstrual Pain Therapy. For more information, please visit www.bielcorp.com .
BioElectronics Corporation 301-874-4980 info@bielcorp.com 4539 Metropolitan Court Frederick, MD 21704
(0)
(0)